Apr 29, 2020
Windtree Announces First Patient Enrolled in AEROSURF® Bridging Study for the Treatment of Respiratory Distress Syndrome
Apr 09, 2020
Celularity Expands Strategic Collaboration with United Therapeutics Corporation to COVID-19 Infection and Acute Respiratory Distress Syndrome
Apr 08, 2020
Lamellar Biomedical Launches Program Designed to Prevent the Severe Respiratory Effects of COVID-19, Using its Unique LAMELLASOME(TM) Technology
Apr 01, 2020
FibroGenesis Files Expanded Patent Coverage for its Fibroblast Cell Therapy to treat Coronavirus (COVID-19) ARDS
Mar 24, 2020
Windtree to Pursue Clinical Study of Lung Injury Treatment in COVID-19 Patients with its KL4 Surfactant Therapy
Mar 10, 2020
FibroGenesis Files Patent Using its Fibroblast Cell Therapy for Coronavirus (COVID-19) ARDS
Sep 06, 2019
Windtree Therapeutics Announces Publication of Results of Lung Deposition Study of Aerosolized Lucinactant
Jun 19, 2019
Windtree Therapeutics to Host Research & Development Day in New York City on June 25
May 06, 2019
Mallinckrodt Announces Encouraging Interim Analysis Results in Phase 4 Registry of INOmax® (Nitric Oxide) Gas for Inhalation for Pulmonary Hypertension in Neonates
May 06, 2019
SIME Completes Study Validating Clinical AI Platform in Neonatal Respiratory Care
Dec 10, 2018
New Data from the AEROSURF® Phase 2b Clinical Program shows AEROSURF® Appears to Reduce Incidence and Severity of Bronchopulmonary Dysplasia in Preterm Infants with RDS
Jul 23, 2018
Windtree Announces Completion of New Design Development for its Aerosol Delivery System (ADS) including Successful Performance Testing
May 31, 2018
Windtree Therapeutics' Aerosolized KL4 Surfactant Preclinical Data in Influenza Presented at the 2018 American Thoracic Society Meeting
May 22, 2018
Windtree Receives $0.7 Million SBIR Grant in Continuing Support of the AEROSURF® Phase 2b Clinical Trial Completion
Dec 28, 2017
Windtree Therapeutics to Provide AEROSURF® and Business Updates
Dec 07, 2017
Aerogen Pharma and Lyomark Pharma Partner to Develop Inhaled Surfactant, Begin a Phase 2 Clinical Trial
Nov 01, 2017
Windtree Successfully Completes Financial Restructuring Program
Aug 18, 2017
Windtree Announces Initiation of Financial Restructuring Program
Jul 25, 2017
AzarGen Biotechnologies Granted European Patent for Plant-Made PRODUCTION OF RECOMBINANT HUMAN SURFACTANT PROTEIN-B
Jun 12, 2017
Windtree Therapeutics and Lee's Pharmaceutical (HK) Limited Enter Into Exclusive License and Collaboration Agreement for Development and Commercialization of KL4 Surfactant Technology Platform in Asia